RT Book, Section
A1 Cohn, Steven L.
A2 Cohn, Steven L.
SR Print(0)
ID 1179530699
T1 Prevention of Infective Endocarditis
T2 Decision Making in Perioperative Medicine: Clinical Pearls
YR 2021
FD 2021
PB McGraw Hill
PP New York, NY
SN 9781260468106
LK accessmedicine.mhmedical.com/content.aspx?aid=1179530699
RD 2024/04/24
AB Infective  endocarditis  (IE)  is  thought  to  result  from  formation  of  nonbacterial  thrombotic  endocarditis  (platelets  and  fibrin)  on  the  surface  of  a  valve  or  damaged  endothelial  surface,  bacteremia  with  adherence  to  the  fibrin-platelet  matrix,  and  proliferation  of  the  bacteria  within  the  vegetation.  The  annual  incidence  of  IE  has  been  increasing  from  2000  to  2011  and  ranges  from  3  to  10  episodes/100,000  population  worldwide  and  11  to  15/100,000  in  the  U.S.  with  a  male  predominance.  Incidence  of  native-valve  IE  has  decreased,  while  IE  related  to  prosthetic  valves  and  cardiac  devices  has  increased.